of C Cells and Medullary Thyroid Carcinoma

Jun 6, 2017 by in ONCOLOGY Comments Off on of C Cells and Medullary Thyroid Carcinoma

Fig. 1 Normal thyroid gland with immunohistochemically demonstrated C cells. The predominantly disperse distributed C cells are located intrafollicular (calcitonin immunohistochemistry, ×200) Some decades later, electron microscopic studies supported the observation…

read more

Thyroid Carcinoma: Imaging

Jun 6, 2017 by in ONCOLOGY Comments Off on Thyroid Carcinoma: Imaging

Fig. 1 Longitudinal US section of the left thyroid lobe, showing a sharply but irregularly delineated, hypoechogenic medullary thyroid carcinoma (arrows) with internal microcalcifications (open arrow) Fig. 2 Transverse (a) and longitudinal…

read more

C-Cell Biology and Oncogenic Transformation

Jun 6, 2017 by in ONCOLOGY Comments Off on C-Cell Biology and Oncogenic Transformation

Fig. 1 RET receptor activation. Shown is a schematic figure outlining the basic structural organization of the transmembrane receptor tyrosine kinase RET and the pathway to its activation. One of the…

read more

in Multiple Endocrine Neoplasia Type 2

Jun 6, 2017 by in ONCOLOGY Comments Off on in Multiple Endocrine Neoplasia Type 2

Fig. 1 Histology of pheochromocytoma. a Pheochromocytoma demonstrates a typical nested architecture (H&E, original magnification 100×). b At high power, the pheochromocytoma cells demonstrate a granular amphophilic cytoplasm and moderate nuclear…

read more

Treatment of Medullary Thyroid Cancer

Jun 6, 2017 by in ONCOLOGY Comments Off on Treatment of Medullary Thyroid Cancer

Period Milestone Mid-nineteenth century Case reports on medullary thyroid cancer (MTC) as a rare tumor entity among young adults within the spectrum of thyroid cancers (Gurlt 1861; Billroth 1869; Wölfer…

read more

and Clinical Presentation of Medullary Thyroid Carcinoma

Jun 6, 2017 by in ONCOLOGY Comments Off on and Clinical Presentation of Medullary Thyroid Carcinoma

Variety of MTC Incidence Age at clinical diagnosis Associated endocrinopathies Sporadic MTC 75 5th decade None Hereditary MTC 25   – MEN2A –23 3rd decade Pheochromocytoma Parathyroid adenoma Cutaneous lichen amyloidosis…

read more

Follow-up in Medullary Thyroid Carcinoma

Jun 6, 2017 by in ONCOLOGY Comments Off on Follow-up in Medullary Thyroid Carcinoma

Kouvaraki MA, Shapiro SE, Fornage BD, Edeiken-Monro BS, Sherman SI, Vassilopoulou-Sellin R et al (2003) Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 134(6):946–954…

read more

Hyperparathyroidism in MEN2 Syndromes

Jun 6, 2017 by in ONCOLOGY Comments Off on Hyperparathyroidism in MEN2 Syndromes

ret codon A/A change in MEN2 syndromes ATA risk level Primary hyperparathyroidism C609F/R/G/S/Y B  C611R/G/F/S/W/Y B  C618R/G/F/S/Y B  C620R/G/F/S/W/Y B  C630R/F/S/Y B Rare D631Y B Rare 633/9 base pair duplication…

read more

as Biomarker for the Medullary Thyroid Carcinoma

Jun 6, 2017 by in ONCOLOGY Comments Off on as Biomarker for the Medullary Thyroid Carcinoma

Fig. 1 Organization of the calcitonin/calcitonin gene-related peptide gene and its peptide hormone products. CTN calcitonin, CGRP calcitonin gene-related peptide, KC katacalcin, SP signal peptide, K lysine, R arginine, G glycine,…

read more
Get Clinical Tree app for offline access